Clinical Trial: A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789015) titled 'A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies' on Aug. 24.

Brief Summary: This study is open to adults aged 18 and older who have a condition known as active idiopathic inflammatory myopathy (IIM) or myositis. People can participate if they have a specific type of myositis. The purpose of this study is to find out whether a medicine called nerandomilast improves IIM symptoms.

Participants are put into 2 groups randomly, which means by chance. One group takes nerandomilast tablets and the other group takes placebo tablets. Placebo tablets look like nerandomilast tablets but do...